Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- N/A
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
A Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Locally Recurrent or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
IMaging PAtients for Cancer Drug selecTion - Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Changes in Phenotype and Genotype of Breast Cancers During the Metastatic Process and Optimization of Therapeutic Targeting (ESOPE)
- Status
- TERMINATED
- Phase
- NA
Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)
- Status
- COMPLETED
- Phase
- PHASE3
First Line Metastatic Breast Cancer Treatment (ESMERALDA)
- Status
- COMPLETED
- Phase
- PHASE2
IMAGE Study: Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins
- Status
- COMPLETED
- Phase
- NA
Phase Ib/II Trials of RAD001 in Triple Negative Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Hepatic Artery Infusion With FOLFOX in Liver Metastasis From Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
8 Continuous vs 8 Intermittent Cycles in First and Second Line in HER2/Neu Neg Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Polymorphism Interaction to Predict Bevacizumab Efficacy
- Status
- COMPLETED
- Phase
- N/A
Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Phase II Study of Eribulin Mesylate, Trastuzumab, and Pertuzumab in Women With Metastatic, Unresectable Locally Advanced, or Locally Recurrent HER2-Positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Pilot Study Assessing Efficacy of a Cisplatin - Metronomic Cyclophosphamide Treatment in Patients With Metastatic Triple Negative Breast Cancer Resistant to Anthracyclines and Taxanes
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Pilot Study Assessing Efficacy of a Cisplatin - Métronomic Cyclophosphamide Treatment in Patients With Stade IV Triple Negative Breast Cancer Secondary Resistant to Anthracyclines and Taxanes
- Status
- TERMINATED
- Phase
- PHASE2
Capecitabine With Digoxin for Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Stereotactic Body Radiation and Monoclonal Antibody to OX40 (MEDI6469) in Breast Cancer Patients With Metastatic Lesions
- Status
- COMPLETED
- Phase
- PHASE1
BP-C1 in Metastatic Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1